TNFRSF18 Antikörper (C-Term)
Kurzübersicht für TNFRSF18 Antikörper (C-Term) (ABIN202993)
Target
Alle TNFRSF18 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Human TNFRSF18
-
Homologie
- Percent identity by BLAST analysis: Human (100%).
-
Aufreinigung
- Protein A/G purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human TNFRSF18 (NP_683700). Percent identity by BLAST analysis: Human, Gorilla (100%), Monkey, Elephant (92%), Galago (85%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized.
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- TNFRSF18 (Tumor Necrosis Factor Receptor Superfamily, Member 18 (TNFRSF18))
-
Andere Bezeichnung
- TNFRSF18 / GITR
-
Hintergrund
-
Name/Gene ID: TNFRSF18
Family: TNF Receptor
Synonyms: TNFRSF18, AITR, CD357, CD357 antigen, GITR, GITR-D -
Gen-ID
- 8784
-
NCBI Accession
- NP_683700
-
UniProt
- Q9Y5U5
-
Pathways
- Cancer Immune Checkpoints
Target
-